Attenuation of NF-κB signalling in rat cardiomyocytes at birth restricts the induction of inflammatory genes

Cardiovascular Research

Volumn 64, Issue 2, 2004, Pages 289-297

  Goren, Nora ^b   Cuenca, Jimena ^b   Martín Sanz, Paloma ^b   Boscá, Lisardo ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b NONE

Author keywords

Inflammation; Myocytes; Nitric oxide; Oxygen radicals; Prostaglandins

Indexed keywords

CYCLOOXYGENASE 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; ISOENZYME; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; PROSTAGLANDIN SYNTHASE;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DNA MICROARRAY; ENZYME ACTIVATION; FETUS; GENE EXPRESSION; GENE REPRESSION; HEART MUSCLE CELL; INFLAMMATORY INFILTRATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECT; IMMUNOLOGY; METABOLISM; NEWBORN; STIMULATION; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CYCLOOXYGENASE 2; ENZYME ACTIVATION; ISOENZYMES; LIPOPOLYSACCHARIDES; MYOCYTES, CARDIAC; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; STIMULATION, CHEMICAL;

EID: 5444230684     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.06.029     Document Type: Article

References (31)

1. M.W. Hornef, M.J. Wick, M. Rhen, and S. Normark Bacterial strategies for overcoming host innate and adaptive immune responses Nat. Immunol. 3 2002 1033 1040
2. P. Knuefermann, S. Nemoto, and G. Baumgarten Cardiac inflammation and innate immunity in septic shock: is there a role for toll-like receptors? Chest 121 2002 1329 1336
3. C.R. Raetz, and C. Whitfield Lipopolysaccharide endotoxins Annu. Rev. Biochem. 71 2002 635 700
4. S.D. Bradford, K. Hunter, Y. Wu, C. Jablonowski, J.J. Bahl, and D.F. Larson Modulation of the inflammatory response in the cardiomyocyte and macrophage J. Extra-Corpor. Technol. 33 2001 167 174
5. Y. Seko, N. Kayagaki, K. Seino, H. Yagita, K. Okumura, and R. Nagai Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3 J. Am. Coll. Cardiol. 39 2002 1399 1403
6. Z. Qian, R. Gelzer-Bell, and S.X. Yang Inducible nitric oxide synthase inhibition of weibel-palade body release in cardiac transplant rejection Circulation 104 2001 2369 2375
7. M. Koyanagi, K. Egashira, and S. Kitamoto Role of monocyte chemoattractant protein-1 in cardiovascular remodeling induced by chronic blockade of nitric oxide synthesis Circulation 102 2000 2243 2248
8. W.H. Frishman, and A.A. Ismail Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target? Cardiol. Rev. 10 2002 199 210
9. K. Kinugawa, T. Shimizu, A. Yao, O. Kohmoto, T. Serizawa, and T. Takahashi Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes Circ. Res. 81 1997 911 921
10. Y.Y. Li, and A.M. Feldman Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications Drugs 61 2001 1239 1252
11. S. Frantz, D. Fraccarollo, and H. Wagner Sustained activation of nuclear factor kB and activator protein 1 in chronic heart failure Cardiovasc. Res. 57 2003 749 756
12. D.A. Norman, M.H. Yacoub, and P.J. Barton Nuclear factor NF-κB in myocardium: developmental expression of subunits and activation by interleukin-1β in cardiac myocytes in vitro Cardiovasc. Res. 39 1998 434 441
13. O. Yokoseki, J. Suzuki, and H. Kitabayashi cis Element decoy against nuclear factor-κB attenuates development of experimental autoimmune myocarditis in rats Circ. Res. 89 2001 899 906
14. D.L. Carlson, D.J. White, D.L. Maass, R.C. Nguyen, B. Giroir, and J.W. Horton I κB overexpression in cardiomyocytes prevents NF-κB translocation and provides cardioprotection in trauma Am. J. Physiol, Heart Circ. Physiol. 284 2003 H804 H814
15. T. Force, S. Haq, H. Kilter, and A. Michael Apoptosis signal-regulating kinase/nuclear factor-κB: a novel signaling pathway regulates cardiomyocyte hypertrophy Circulation 105 2002 402 404
16. B. Chandrasekar, J.B. Smith, and G.L. Freeman Ischemia-reperfusion of rat myocardium activates nuclear factor-κB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine Circulation 103 2001 2296 2302
17. M.L. Lam, M. Bartoli, and W.C. Claycomb The 21-day postnatal rat ventricular cardiac muscle cell in culture as an experimental model to study adult cardiomyocyte gene expression Mol. Cell. Biochem. 229 2002 51 62
18. A.M. Gomez, J.P. Benitah, D. Henzel, A. Vinet, P. Lorente, and C. Delgado Modulation of electrical heterogeneity by compensated hypertrophy in rat left ventricle Am. J. Physiol. 272 1997 H1078 H1086
19. 2 in activated murine macrophages Mol. Cell. Biol. 20 2000 1692 1698
20. J. Sirois, L.O. Levy, D.L. Simmons, and J.S. Richards Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Identification of functional and protein-binding regions J. Biol. Chem. 268 1993 12199 12206
21. N.A. Callejas, L. Bosca, C.S. Williams, R.N. DuBois, and P. Martin-Sanz Regulation of cyclooxygenase-2 expression in hepatocytes by CCAAT-enhancer binding proteins Gastroenterology 119 2000 493 501
22. M.J.M. Diaz-Guerra, M. Velasco, P. Martin-Sanz, and L. Bosca Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes. Requirement of NF-κB activation after stimulation with bacterial cell wall products and phorbol esters J. Biol. Chem. 271 1996 30114 30120
23. N.P. Lewis, P.S. Tsao, and P.R. Rickenbacher Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle Circulation 93 1996 720 729
24. F. Sam, D.B. Sawyer, and Z. Xie Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction Circ. Res. 89 2001 351 356
25. G. Valen, G.K. Hansson, A. Dumitrescu, and J. Vaage Unstable angina activates myocardial heat shock protein 72, endothelial nitric oxide synthase, and transcription factors NFκB and AP-1 Cardiovasc. Res. 47 2000 49 56
26. P.B. Massion, O. Feron, C. Dessy, and J.L. Balligand Nitric oxide and cardiac function: ten years after, and continuing Circ. Res. 93 2003 388 398
27. L.J. Ignarro, C. Napoli, and J. Loscalzo Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview Circ. Res. 90 2002 21 28
28. R. Bolli, K. Shinmura, and X.L. Tang Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning Cardiovasc. Res. 55 2002 506 519
29. A. Abbate, D. Santini, and G.G. Biondi-Zoccai Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe? Heart 90 2004 440 443
30. R.M. Delgado III, M.A. Nawar, and A.M. Zewail Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure Circulation 109 2004 1428 1433
31. M.C. LaPointe, M. Mendez, A. Leung, Z. Tao, and X.P. Yang Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse Am. J. Physiol, Heart Circ. Physiol. 286 2004 H1416 H1424